IRIS Accounts Production v25.1.0.734 10418506 Board of Directors 1.1.24 31.12.24 31.12.24 false true false false true false Fair value model Ordinary 'A' 1.00000 Ordinary 'B' 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh104185062023-12-31104185062024-12-31104185062024-01-012024-12-31104185062022-12-31104185062023-01-012023-12-31104185062023-12-3110418506ns15:EnglandWales2024-01-012024-12-3110418506ns14:PoundSterling2024-01-012024-12-3110418506ns10:Director12024-01-012024-12-3110418506ns10:PrivateLimitedCompanyLtd2024-01-012024-12-3110418506ns10:SmallEntities2024-01-012024-12-3110418506ns10:AuditExempt-NoAccountantsReport2024-01-012024-12-3110418506ns10:SmallCompaniesRegimeForDirectorsReport2024-01-012024-12-3110418506ns10:SmallCompaniesRegimeForAccounts2024-01-012024-12-3110418506ns10:FullAccounts2024-01-012024-12-3110418506ns10:OrdinaryShareClass12024-01-012024-12-3110418506ns10:OrdinaryShareClass22024-01-012024-12-3110418506ns10:Director22024-01-012024-12-3110418506ns10:RegisteredOffice2024-01-012024-12-3110418506ns5:CurrentFinancialInstruments2024-12-3110418506ns5:CurrentFinancialInstruments2023-12-3110418506ns5:ShareCapital2024-12-3110418506ns5:ShareCapital2023-12-3110418506ns5:RetainedEarningsAccumulatedLosses2024-12-3110418506ns5:RetainedEarningsAccumulatedLosses2023-12-3110418506ns5:LeaseholdImprovements2023-12-3110418506ns5:PlantMachinery2023-12-3110418506ns5:FurnitureFittings2023-12-3110418506ns5:LeaseholdImprovements2024-01-012024-12-3110418506ns5:PlantMachinery2024-01-012024-12-3110418506ns5:FurnitureFittings2024-01-012024-12-3110418506ns5:LeaseholdImprovements2024-12-3110418506ns5:PlantMachinery2024-12-3110418506ns5:FurnitureFittings2024-12-3110418506ns5:LeaseholdImprovements2023-12-3110418506ns5:PlantMachinery2023-12-3110418506ns5:FurnitureFittings2023-12-3110418506ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3110418506ns5:WithinOneYearns5:CurrentFinancialInstruments2023-12-3110418506ns5:DeferredTaxation2023-12-3110418506ns5:DeferredTaxation2024-12-3110418506ns10:OrdinaryShareClass12024-12-3110418506ns10:OrdinaryShareClass22024-12-31
REGISTERED NUMBER: 10418506 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2024

FOR

GLYCINE HOLDINGS LIMITED

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


GLYCINE HOLDINGS LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 DECEMBER 2024







DIRECTORS: C Davis
S B Davis





REGISTERED OFFICE: Glycine House
Hampton Court Road
East Molesey
Surrey
KT8 9BZ





REGISTERED NUMBER: 10418506 (England and Wales)





ACCOUNTANTS: Lawes & Co
Boyce's Building
40-42 Regent Street
Clifton
Bristol
BS8 4HU

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

BALANCE SHEET
31 DECEMBER 2024

31.12.24 31.12.23
Notes £    £    £   
FIXED ASSETS
Tangible assets 4 71,286 70,281
Investment property 5 1,295,000 1,325,000
1,366,286 1,395,281

CURRENT ASSETS
Debtors 6 18,810 34,226
Cash at bank 17,766 2,551
36,576 36,777
CREDITORS
Amounts falling due within one year 7 1,312,629 1,321,157
NET CURRENT LIABILITIES (1,276,053 ) (1,284,380 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

90,233

110,901

PROVISIONS FOR LIABILITIES 8 26,832 31,444
NET ASSETS 63,401 79,457

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 63,301 79,357
SHAREHOLDERS' FUNDS 63,401 79,457

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

BALANCE SHEET - continued
31 DECEMBER 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 12 May 2025 and were signed on its behalf by:





C Davis - Director


GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1. STATUTORY INFORMATION

Glycine Holdings Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Investment properties and improvements to the investment properties are measured using revaluation and are not depreciated.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

4. TANGIBLE FIXED ASSETS
Improvements Fixtures
to Plant and and
property machinery fittings Totals
£    £    £    £   
COST
At 1 January 2024 65,469 4,357 5,499 75,325
Additions - 2,976 - 2,976
At 31 December 2024 65,469 7,333 5,499 78,301
DEPRECIATION
At 1 January 2024 - 4,357 687 5,044
Charge for year - 596 1,375 1,971
At 31 December 2024 - 4,953 2,062 7,015
NET BOOK VALUE
At 31 December 2024 65,469 2,380 3,437 71,286
At 31 December 2023 65,469 - 4,812 70,281

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 January 2024 1,325,000
Revaluations (30,000 )
At 31 December 2024 1,295,000
NET BOOK VALUE
At 31 December 2024 1,295,000
At 31 December 2023 1,325,000

Fair value at 31 December 2024 is represented by:
£   
Valuation in 2021 57,827
Valuation in 2022 43,916
Valuation in 2023 19,323
Valuation in 2024 (30,000 )
Cost 1,203,934
1,295,000

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade debtors 17,398 24,444
Other debtors 1,412 9,782
18,810 34,226

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.12.24 31.12.23
£    £   
Trade creditors 618 4,154
Taxation and social security 79 -
Other creditors 1,311,932 1,317,003
1,312,629 1,321,157

8. PROVISIONS FOR LIABILITIES
31.12.24 31.12.23
£    £   
Deferred tax 26,832 31,444

Deferred
tax
£   
Balance at 1 January 2024 31,444
Accelerated capital allowances 251
Revaluation (7,500 )
Tax on losses 2,637
Balance at 31 December 2024 26,832

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.12.24 31.12.23
value: £    £   
50 Ordinary 'A' £1 50 50
50 Ordinary 'B' £1 50 50
100 100

10. RELATED PARTY DISCLOSURES

The directors maintain interest free loan accounts with the company. At the balance sheet date, the company owed the directors £1,310,083 (2023: £1,315,152 ).

GLYCINE HOLDINGS LIMITED (REGISTERED NUMBER: 10418506)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 DECEMBER 2024

11. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.